CSIR Central

Green synthesis of zinc oxide nanoparticle using <em>Pentatropis capensis</em> and its anti-proliferative activity

IR@NISCAIR: CSIR-NISCAIR, New Delhi - ONLINE PERIODICALS REPOSITORY (NOPR)

View Archive Info
 
 
Field Value
 
Title Green synthesis of zinc oxide nanoparticle using <em>Pentatropis capensis</em> and its anti-proliferative activity
 
Creator Surekha, K.
Abirami, R.
Prasidhee, V.
Jacob, S. Justin Packia
 
Subject Anti-proliferative
EDAX
FTIR
Green synthesis
SEM
UV-Vis
ZnO nanoparticle
 
Description 316-321
The ZnO nanoparticle synthesised by green synthesis method using aerial parts of <em>Pentatropis capensis</em> was characterised using UV-Vis spectroscopy, FTIR, SEM, and EDAX. The antiproliferative activity was tested against HepG2 and MCF-7 cell lines by MTT assay and the IC<sub>50</sub> value was calculated.The absorption peak at 330 nm confirms the presence of ZnO nanoparticle. The FTIR spectra of synthesised ZnO nanoparticle confirm the various groups present in it. The SEM image reveals the size of ZnO nanoparticle, which ranged from 73.4-398.3 nm. The elemental composition of ZnO nanoparticles consists of zinc, carbon, oxygen, potassium, calcium, and chlorine which was determined in EDAX analysis. The IC<sub>50</sub> value of anti-proliferative activity was found to be 23.277 µg/mL for HepG2 cell line and 12.926 µg/mL for the MCF-7 cell line. The green synthesised ZnO nanoparticle showed an effective anti-proliferative activity on both HepG2 and MCF cell line.
 
Date 2018-03-28T10:40:42Z
2018-03-28T10:40:42Z
2017-12
 
Type Article
 
Identifier 0976-0512 (Online); 0976-0504 (Print)
http://nopr.niscair.res.in/handle/123456789/44141
 
Language en_US
 
Relation Int. cl. (2015.01)- A61K 36/00, A61K 36/24
 
Rights <img src='http://nopr.niscair.res.in/image/cc-license-sml.png'> <a href='http://creativecommons.org/licenses/by-nc-nd/2.5/in' target='_blank'>CC Attribution-Noncommercial-No Derivative Works 2.5 India</a>
 
Publisher NISCAIR-CSIR, India
 
Source IJNPR Vol.8(4) [December 2017]